Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection
C Tincati, DC Douek, G Marchetti - AIDS research and therapy, 2016 - Springer
Over the past 10 years, extensive work has been carried out in the field of microbial
translocation in HIV infection, ranging from studies on its clinical significance to …
translocation in HIV infection, ranging from studies on its clinical significance to …
[HTML][HTML] Focus: Infectious diseases: Mechanisms of virologic control and clinical characteristics of HIV+ elite/viremic controllers
E Gonzalo-Gil, U Ikediobi, RE Sutton - The Yale journal of biology …, 2017 - ncbi.nlm.nih.gov
Human immunodeficiency virus type 1 (HIV-1) disease is pandemic, with approximately 36
million infected individuals world-wide. For the vast majority of these individuals, untreated …
million infected individuals world-wide. For the vast majority of these individuals, untreated …
HIV persists in CCR6+ CD4+ T cells from colon and blood during antiretroviral therapy
A Gosselin, TRW Salinas, D Planas, VS Wacleche… - Aids, 2017 - journals.lww.com
Objectives: The objective of this article is to investigate the contribution of colon and blood
CD4+ T-cell subsets expressing the chemokine receptor CCR6 to HIV persistence during …
CD4+ T-cell subsets expressing the chemokine receptor CCR6 to HIV persistence during …
Probiotic supplementation promotes a reduction in T‐cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and …
G d'Ettorre, G Rossi, C Scagnolari… - Immunity …, 2017 - Wiley Online Library
Introduction HIV infection is characterized by a persistent immune activation associated to a
compromised gut barrier immunity and alterations in the profile of the fecal flora linked with …
compromised gut barrier immunity and alterations in the profile of the fecal flora linked with …
[HTML][HTML] Combination anti–PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
GH Mylvaganam, LS Chea, GK Tharp, S Hicks, V Velu… - JCI insight, 2018 - ncbi.nlm.nih.gov
Therapeutic strategies that augment antiviral immunity and reduce the viral reservoir are
critical to achieving durable remission of HIV. The coinhibitory receptor programmed death-1 …
critical to achieving durable remission of HIV. The coinhibitory receptor programmed death-1 …
IL-21 and IFNα therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques
Unlike HIV infection, which progresses to AIDS absent suppressive anti-retroviral therapy,
nonpathogenic infections in natural hosts, such African green monkeys, are characterized by …
nonpathogenic infections in natural hosts, such African green monkeys, are characterized by …
Identification of novel HIV-1 dependency factors in primary CCR4+CCR6+Th17 cells via a genome-wide transcriptional approach
A Cleret-Buhot, Y Zhang, D Planas, JP Goulet… - Retrovirology, 2015 - Springer
Background The HIV-1 infection is characterized by profound CD4+ T cell destruction and a
marked Th17 dysfunction at the mucosal level. Viral suppressive antiretroviral therapy …
marked Th17 dysfunction at the mucosal level. Viral suppressive antiretroviral therapy …
The prevention of 2, 4-dinitrochlorobenzene-induced inflammation in atopic dermatitis-like skin lesions in BALB/c mice by Jawoongo
JM Ku, SH Hong, SR Kim, HS Choi, HI Kim… - … and alternative medicine, 2018 - Springer
Background Jawoongo is an herbal mixture used in traditional medicine to treat skin
diseases. This study aimed to investigate whether Jawoongo ameliorates Atopic dermatitis …
diseases. This study aimed to investigate whether Jawoongo ameliorates Atopic dermatitis …
Modeling the mechanisms by which HIV-associated immunosuppression influences HPV persistence at the oral mucosa
Human immunodeficiency virus (HIV)-infected patients are at an increased risk of co-
infection with human papilloma virus (HPV), and subsequent malignancies such as oral …
infection with human papilloma virus (HPV), and subsequent malignancies such as oral …
Preservation of gastrointestinal mucosal barrier function and microbiome in patients with controlled HIV infection
G Mak, JJ Zaunders, M Bailey, N Seddiki… - Frontiers in …, 2021 - frontiersin.org
Background Despite successful ART in people living with HIV infection (PLHIV) they
experience increased morbidity and mortality compared with HIV-negative controls. A …
experience increased morbidity and mortality compared with HIV-negative controls. A …